%0 Journal Article
%K Humans
%K Male
%K *Muscular Dystrophy, Duchenne/epidemiology/therapy
%K Retrospective Studies
%K Longitudinal Studies
%K Adrenal Cortex Hormones
%K *Cardiomyopathies/complications
%K United Kingdom/epidemiology
%K Duchenne muscular dystrophy
%K Economic models
%K Electronic Health Records
%K statistical models
%K fees from Duchenne UK. Michela Guglieri has received research funding from
%K Sarepta, PTC, Muscular Dystrophy UK, NIH and H2020
%K is (or has been) chief
%K investigator/principal investigator for clinical trials of Pfizer, Italfarmaco,
%K Santhera, Roche, ReveraGen, Dynacure, Dyne
%K is a member of Advisory boards for
%K Pfizer, NS Pharma, Dyne (honoraria through Newcastle University)
%K and has
%K received speaker honoraria from Sarepta, Italfarmaco, Novartis and Roche.
%B Brain Behav
%D 2023
%G eng
%M 37957895
%P e3331
%R 10.1002/brb3.3331
%T Natural history of Duchenne muscular dystrophy in the United Kingdom: A descriptive study using the Clinical Practice Research Datalink
%V 13
%2 PMC10726817
%7 2023/11/14